Loading...

And the rates of major bleeding issues in patients were similar between the two drugs. And so that's also a concern that may lead to more bleeding complications. And writing in the Lancet, the study team said that this comprehensive synthesis of available evidence indicates that in patients with CAD, long-term labic monotherapy offers a superior protection against major cardiovascular and cerebrovascular events compared with aspirin without an increase of excess bleeding events.